To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1

Safety and Tolerability Study of Sublingual Lobeline

To assess the safety and tolerability of 7.5, 15 and 30 mg of sublingual lobeline.

The primary objective of this study is to characterize the pharmacokinetics of three ascending doses of lobeline in normal volunteers.

Inclusion Criteria:

• Healthy individuals with a body mass index between 18 and 30.
• Willing and able to give written consent.
• Must have a negative drug test
• Females must have a negative pregnancy test prior to study drug administration
• Must have no medical contraindications as determined by routine testing

Exclusion Criteria:

• Please contact the site for more information